نتایج جستجو برای: chronic lymphocytic leukemia

تعداد نتایج: 733768  

Journal: :international journal of hematology-oncology and stem cell research 0
mehrdad payandeh medical biology research center, kermanshah university of medical sciences, kermanshah, iran. edris sadeghi department of nursing, borujerd branch, islamic azad university, borujerd, iran. reza khodarahmi medical biology research center, kermanshah university of medical sciences, kermanshah, iran. masoud sadeghi medical biology research center, kermanshah university of medical sciences, kermanshah, iran.

chronic lymphocytic leukemia (cll) and chronic myeloid leukemia (cml) are the most common leukemias of the elderly (>43 year). however, the sequential occurrence of cml followed by cll in the same patient is extremely rare. in our report, a 52-year-old female was diagnosed with cll (type of bone marrow (bm) infiltration was nodular and interstitial) and was treated with chlorambucil. 64 months ...

Journal: :avicenna journal of medical biotechnology 0

it has recently been shown that ror1, a member of the receptor tyrosine kinase family, is overexpressed in leukemic b cells of chronic lymphocytic leukemia (cll) and a subset of acute lymphoblastic leukemia (all). in this comparative study the expression profile of ror1 mrna was investigated in iranian patients with cll and acute myelogenous leukemia (aml) and the results were compared with tho...

Journal: :iranian journal of cancer prevention 0
mehrdad payandeh 1. pennathur a, gibson mk, jobe ba, luketich jd. oesophageal carcinoma.lancet. 2013;381(9864):400-12. 2. ferlay j, shin hr, bray f, forman d, mathers c, parkin dm.estimates of worldwide burden of cancer in 2008: globocan 2008. int j cancer. 2010;127:2893–917. 3. lepage c, rachet b, jooste v, faivre j, coleman mp. continuing rapid increase in sophageal adenocarcinoma in england and wales. am j gastroentero.l 2008;103 2694–99. 4. pennathur a, farkas a, krasinskas am. esophagectomy for t1 esophageal cancer: outcomes in 100 patients and implications for endoscopic therapy. ann thorac surg. 2009;87:1048–55. 5. mir mr, rajabpour mv, delarestaghi mm, hadji m, harirchi i, mir p, mir a, lashkari m, zendehdel k. short- and long-term survival of esophageal cancer patients treated at the cancer institute of iran. dig surg. 2013;30(4-6):331-6. 6. harirchi i, kolahdoozan s, hajizadeh s, safari f, sedighi z, nahvijou a, mir mr, mousavi sm, zendehdel k. esophageal cancer in iran; a population-based study regarding adequacy of cancer surgery and overall survival. eur j surg oncol. 2014;40(3):352-7. 7. pennathur a, luketich jd. resection for esophageal cancer:strategies for optimal management. ann thorac surg. 2008;85:751–56. 8. pennathur a, zhang j, chen h, luketich jd. the “best operation”for esophageal cancer? ann thorac surg. 2010;89:2163–67. 9. davies ar, forshaw mj, khan aa, noorani as, patel vm, strauss dc, mason rc. transhiatal esophagectomy in a high volume institution. world j surg oncol. 2008 ;6:88. 10. chang ac, ji h, birkmeyer nj, orringer mb, birkmeyer jd. outcomes after transhiatal and transthoracic esophagectomy for cancer. ann thorac surg. 2008;85(2):424-9. 11. nikbakhsh n, amri p, shakeri a, shakeri a. changes in blood pressure and heart rhythm during transhiatal esophagectomy.caspian j intern med. 2012;3(4):541-5. 12. mallipeddi mk, onaitis mw. the contemporary role of minimally invasive esophagectomy in esophageal cancer. curr oncol rep. 2014;16(3):374. 13. sundaram a, geronimo jc, willer bl, hoshino m, torgersen z, juhasz a, lee th, mittal sk. survival and quality of life after minimally invasive esophagectomy: a single-surgeon experience. surg endosc. 2012;26(1):168-76. 14. herbella fa, patti mg. minimally invasive esophagectomy. world j gastroenterol. 2010;16(30):3811-5. 15. rice tw, blackstone eh, rusch vw. 7th edition of the ajcc cancer staging manual: esophagus and esophagogastric junction.ann surg oncol. 2010;17(7):1721-4 16. d'journo xb, thomas pa. current management of esophageal cancer. j thorac dis. 2014;6 suppl 2:s253-64. 17.hoppo t, jobe ba, hunter jg. minimally invasive esophagectomy: the evolution and technique of minimally invasive surgery for esophageal cancer. world j surg. 2011;35(7):1454-63. 18. dhamija a, dhamija a, hancock j, mccloskey b, kim aw, detterbeck fc, boffa dj. minimally invasive oesophagectomy more expensive than open despite shorter length of stay. eur j cardiothorac surg. 2014;45(5):904-9. 19. galvani ca, gorodner mv, moser f, jacobsen g, chretien c, espat nj, donahue p, horgan s. robotically assisted laparoscopic transhiatal esophagectomy. surg endosc. 2008;22(1):188-95. 20. nguyen nt, hinojosa mw, smith br, chang kj, gray j, hoyt d. minimally invasive esophagectomy: lessons learned from 104 operations. ann surg. 2008;248(6):1081-91. 21. dunn dh, johnson em, morphew ja, dilworth hp, krueger jl, banerji n. robot-assisted transhiatal esophagectomy: a 3-year single-center experience. dis esophagus. 2013;26(2):159-66. 22. maas kw, biere ss, scheepers jj, gisbertz ss, van-der-peet dl, cuesta ma. laparoscopic versus open transhiatal esophagectomy for distal and junction cancer. rev esp enferm dig. 2012;104(4):197-202. 23. rizvi fh, rizvi ss, syed aa, khattak s, khan ar. minimally invasive esophagectomy for esophageal cancer: the first experience from pakistan. int j surg oncol. 2014;2014:864705. 24. tabatabaie sa., hashemi sm,, mohajeri gh,ahmadinejad m, goharian v, kolahdoozan m.,sehhat s, davarpanah ah. incidence of hypotension and type of arrhythmia in transhiatal esophagectomy and evaluation of related factors.iranian journal of surgery. 2009;16(4):59-68. dept. of hematology and medical oncology, kermanshah university of medical sciences, kermanshah, iran masoud sadeghi students research committee, kermanshah university of medical sciences, kermanshah, iran medical biology research center, kermanshah university of medical sciences, kermanshah, iran edris sadeghi students research committee, kermanshah university of medical sciences, kermanshah, iran medical biology research center, kermanshah university of medical sciences, kermanshah, iran

1. dept. of hematology and medical oncology, kermanshah university of medical sciences, kermanshah, iran 2. students research committee, kermanshah university of medical sciences, kermanshah, iran 3. medical biology research center, kermanshah university of medical sciences, kermanshah, iran                                     corresponding author: masoud sadeghi, msc. tel: (+98) 9185960644 ema...

ژورنال: :iranian red crescent medical journal 0
hamideh jafari ghahfarokhi cellular and molecular research center, shahrekord university of medical sciences, shahrekord, ir iran saeede ashoori cellular and molecular research center, shahrekord university of medical sciences, shahrekord, ir iran mohamad taghi akbari department of medical genetics, faculty of medical sciences, tarbiat modares university, tehran, ir iran masoud lotfizadeh department of public health, social health determinants research center, school of health, shahrekord university of medical sciences, shahrekord, ir iran ali karimi medical plant research center, shahrekord university of medical sciences, shahrekord, ir iran hossein teimori cellular and molecular research center, shahrekord university of medical sciences, shahrekord, ir iran; cellular and molecular research center, shahrekord university of medical sciences, shahrekord, ir iran. tel: +98-3813346692, fax: +98-3813330709

background b-cell chronic lymphocytic leukemia (b-cll) is the most common form of leukemia in adults. some reports showed that expression of zap70 gene and chromosomal abnormality are two prognostic factors in management of b-cll objectives in this study, we determined zap70 mrna expression level in the del17p13, del6q21 and del11q13 subgroups of iranian b-cll patients to investigate prognostic...

Journal: :Encyclopedia 2022

Genome-editing systems such as Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 technology have uncovered new opportunities to model diseases chronic lymphocytic leukemia. CRISPR/Cas9 is an important means of advancing functional studies Chronic Lymphocytic Leukemia (CLL) through the incorporation, elimination and modification somatic mutations in CLL models.

Journal: :iranian red crescent medical journal 0
hossein teimori cellular and molecular research center, school of medicine, shahrekord university of medical sciences, shahrekord, ir iran; cellular and molecular research center, school of medicine, shahrekord university of medical sciences, shahrekord, ir iran. tel: +98-3813346692, fax: +98-3813330709 saeede ashoori cellular and molecular research center, school of medicine, shahrekord university of medical sciences, shahrekord, ir iran mohamad taghi akbari department of medical genetics, faculty of medical sciences, tarbiat modares university, tehran, ir iran marjan mojtabavi naeini cellular and molecular research center, school of medicine, shahrekord university of medical sciences, shahrekord, ir iran morteza hashemzade chaleshtori cellular and molecular research center, school of medicine, shahrekord university of medical sciences, shahrekord, ir iran

conclusions it was demonstrated that the presence of del6q21 in b-cll patients indicates poor prognosis and on the contrary, presence of del17p13 points at the good prognostic value of the disease. results deletion of 17p13 was found in 11 (16.6%) and deletion 6q21 was present in 5 (7.5%). statistical analyses were performed to investigate the correlation of these molecular-cytogenetic findings...

ژورنال: ارمغان دانش 2020

Introduction: Chronic lymphocytic leukemia (CLL) is the most frequent leukemia in adults living in Western countries. with a diverse clinical course that due to life expectancy less than two years between patients finding ,new therapeutic strategies is essential for it. Curcumin as the biologic active of turmeric, has many biological properties such as anti-inflammatory, anti-oxidant, anti-diab...

Journal: :International Journal of Advances in Medicine 2021

Idelalisib is a novel treatment option for patients with chronic lymphocytic leukemia. A rare, but, fatal complication of using Idelalsib drug induced pneumonitis. This article presents case pneumonitis in patient leukemia along brief discussion management plan.

2015
Andrew M. Plata James N. Frame Jeremy Stuelpnagel Tajana Juranovic Oscar C. Estalilla Tomislav M. Jelic

Background: B-cell chronic lymphocytic leukemia is the most frequent leukemia in the western world while T-cell large granular lymphocytic leukemia with cytotoxic (CD8+/CD3+CD4-) immunophenotype is rare. There is much ongoing interest regarding the interaction between T cells and B-cell chronic lymphocytic leukemia cells. Methods: Peripheral blood and bone marrow samples from a 72 year-old-man ...

2017
Martijn HA van Attekum Eric Eldering Arnon P Kater

The importance of the tumor microenvironment in chronic lymphocytic leukemia is widely accepted. Nevertheless, the understanding of the complex interplay between the various types of bystander cells and chronic lymphocytic leukemia cells is incomplete. Numerous studies have indicated that bystander cells provide chronic lymphocytic leukemia-supportive functions, but it has also become clear tha...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید